TranS1

Spinal surgery device firm TranS1 raises $18.3M in stock sale

Medical device company TranS1 (NASDAQ:TSON), which focuses on devices that treat degenerative spinal conditions, has raised about $18.3 million in net proceeds from a stock offering intended to finance clinical trials. The Wilmington, North Carolina-based company priced the stock offering of 6.2 million shares last week. The stock offering follows the May filing of a […]

By Frank Vinluan

Devices & Diagnostics

Medical device firm TranS1 prices stock offering; seeks $20M for clinical trials

Medical device company TranS1 is moving forward with plans to raise up to $20.1 million through a stock offering. The Wilmington, North Carolina-based company today priced its offering of 6.2 million shares at $3.25 per share, a 12 percent discount from the stock’s previous closing price of $3.70. But in midday trading, TranS1 stock was […]

By Frank Vinluan